| answer text |
<p>The following table shows expenditure on research relating to the treatment of
Crohn’s disease and ulcerative colitis by the Medical Research Council, and by the
National Institute for Health (NIHR) through its research programmes, research centres
and units, and research fellowships.</p><p> </p><p> </p><p> </p><p>£ million</p><p>
</p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td
colspan="6"><p>Crohn’s disease</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>3.1</p></td><td><p>3.4</p></td><td><p>2.6</p></td><td><p>2.4</p></td><td><p>2.5</p></td></tr><tr><td><p>National
Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.4</p></td><td><p>0.6</p></td><td><p>0.3</p></td><td><p>0.8</p></td></tr><tr><td
colspan="6"><p>Ulcerative colitis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>1.2</p></td><td><p>1.0</p></td><td><p>0.9</p></td><td><p>0.7</p></td><td><p>0.6</p></td></tr><tr><td><p>National
Institute for Health Research</p></td><td><p>0.6</p></td><td><p>0.7</p></td><td><p>0.9</p></td><td><p>0.8</p></td><td><p>1.0</p></td></tr><tr><td
colspan="6"><p>Crohn’s disease and ulcerative colitis</p></td></tr><tr><td><p>Medical
Research Council<sup>1</sup></p></td><td><p>3.6</p></td><td><p>4.0</p></td><td><p>3.3</p></td><td><p>2.9</p></td><td><p>2.7</p></td></tr></tbody></table><p>
</p><p><em>Note:</em></p><p> </p><p><sup>1</sup> Research looking at both Crohn’s
disease and ulcerative colitis within the same project.</p><p> </p><p> </p><p> </p><p>Total
spend by the NIHR on research relating to the treatment of Crohn’s disease and ulcerative
colitis is higher than the figures shown because expenditure by the NIHR Clinical
Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure.</p><p>
</p><p> </p><p> </p>
|
|
